Insider · CIK 0001376960

Aryeh Jason

Reports to the SEC for 10 companies · NEW HOPE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001376960

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+42.6K sh	—	—	42,553
2026-06-11	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−4,500 sh	$250.00	−$1.13M	102,580
2026-06-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−500 sh	$250.00	−$125K	107,080
2026-06-05	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+836 sh	—	—	107,580
2026-06-05	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,938 sh	—	—	2,938
2026-06-04	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+25.9K sh	—	—	69,967
2026-05-18	OBIOOrchestra BioMed Holdings, Inc.P Purchase	Director	PPurchase	+665 sh	$3.75	+$2,493.75	118,118
2026-05-15	OBIOOrchestra BioMed Holdings, Inc.P Purchase	Director	PPurchase	+8,971 sh	$3.90	+$35K	117,453
2025-12-08	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,034 sh	$69.51	+$141K	71,323
2025-12-08	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,034 sh	—	—	0
2025-09-23	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−4,628 sh	$170.96	−$791K	70,243
2025-09-23	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−954 sh	$171.92	−$164K	69,289
2025-09-23	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−4,418 sh	$170.41	−$753K	74,871
2025-09-19	OBIOOrchestra BioMed Holdings, Inc.P Purchase	Director	PPurchase	+1,000 sh	$2.45	+$2,450	108,482
2025-08-07	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+15K sh	—	—	107,482
2025-07-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+19.5K sh	—	—	44,060
2025-06-24	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+36.8K sh	—	—	36,797
2025-06-24	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+12.4K sh	—	—	92,482
2025-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,209 sh	—	—	79,289
2025-06-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,783 sh	—	—	5,783
2025-04-04	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,964 sh	—	—	4,964
2025-04-04	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-12-27	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	6,900
2024-12-27	OBIOOrchestra BioMed Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	$4.30	+$50.3K	80,060
2024-08-19	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+24.6K sh	—	—	24,554
2024-06-20	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,068
2024-06-20	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+5,376 sh	—	—	68,360
2024-06-14	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,444 sh	—	—	5,444
2024-06-14	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,252 sh	—	—	78,080
2024-06-13	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,482 sh	—	—	2,482
2024-06-13	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+41.7K sh	—	—	41,667
2024-04-30	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,406 sh	$52.30	+$126K	76,828
2024-04-30	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,406 sh	—	—	0
2024-03-05	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,893 sh	$39.35	+$114K	74,422
2024-03-05	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,893 sh	—	—	0
2023-07-20	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,461 sh	—	—	5,461
2023-06-09	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,142 sh	—	—	71,529
2023-04-12	OBIOOrchestra BioMed Holdings, Inc. · Right to Receive Earnout SharesM Exercise/Conversion	Director	MExercise/Conversion	+11.2K sh	—	—	11,246
2023-04-12	OBIOOrchestra BioMed Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.2K sh	—	—	62,984
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Right to Receive Earnout SharesA Award	Director	AAward	+22.5K sh	—	—	22,492
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+6,975 sh	—	—	6,975
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+18.6K sh	—	—	18,600
2023-01-26	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+51.7K sh	—	—	51,738
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2022-12-22	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+4,484 sh	—	—	4,484
2022-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,004 sh	—	—	69,668
2022-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+4,340 sh	—	—	4,340
2022-04-21	ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30.4K sh	—	—	30,425

Recent filings

Accepted (ET)
Jun 254
Aryeh Jason0001104659-26-077771
SEC(opens sec.gov)
Jun 124
Aryeh Jason0002001011-26-000103
SEC(opens sec.gov)
Jun 54
Aryeh Jason0001376960-26-000002
SEC(opens sec.gov)
May 204
Aryeh Jason0001104659-26-064136
SEC(opens sec.gov)
May 194
Aryeh Jason0001104659-26-063511
SEC(opens sec.gov)
Dec 84
Aryeh Jason0002001011-25-000122
SEC(opens sec.gov)
Sep 244
Aryeh Jason0002001011-25-000082
SEC(opens sec.gov)
Sep 194
Aryeh Jason0001104659-25-091775
SEC(opens sec.gov)
Aug 84
Aryeh Jason0001104659-25-075788
SEC(opens sec.gov)
Jul 174
Aryeh Jason0001005286-25-000091
SEC(opens sec.gov)
Jun 274
Aryeh Jason0001104659-25-063692
SEC(opens sec.gov)
Jun 104
Aryeh Jason0002001011-25-000045
SEC(opens sec.gov)

Companies

Address

C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE

NEW HOPE, PA, 18938